NOGUERA, NELIDA INES
 Distribuzione geografica
Continente #
NA - Nord America 10.978
AS - Asia 1.498
EU - Europa 1.306
SA - Sud America 214
AF - Africa 28
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 14.030
Nazione #
US - Stati Uniti d'America 10.918
SG - Singapore 704
IT - Italia 395
CN - Cina 262
BR - Brasile 184
RU - Federazione Russa 179
VN - Vietnam 144
IE - Irlanda 133
HK - Hong Kong 123
DE - Germania 117
UA - Ucraina 109
FR - Francia 95
GB - Regno Unito 63
BD - Bangladesh 62
KR - Corea 47
PL - Polonia 45
FI - Finlandia 42
JP - Giappone 41
CA - Canada 38
IN - India 38
NL - Olanda 33
SE - Svezia 25
MX - Messico 15
ID - Indonesia 14
AT - Austria 13
BE - Belgio 12
TR - Turchia 12
ES - Italia 11
IQ - Iraq 9
AR - Argentina 7
ZA - Sudafrica 7
GR - Grecia 6
TN - Tunisia 6
UZ - Uzbekistan 6
CO - Colombia 5
CZ - Repubblica Ceca 5
EG - Egitto 5
DK - Danimarca 4
EC - Ecuador 4
LT - Lituania 4
PH - Filippine 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CL - Cile 3
JO - Giordania 3
KE - Kenya 3
KZ - Kazakistan 3
PE - Perù 3
PK - Pakistan 3
SA - Arabia Saudita 3
VE - Venezuela 3
AZ - Azerbaigian 2
CH - Svizzera 2
CR - Costa Rica 2
LB - Libano 2
MY - Malesia 2
NG - Nigeria 2
PT - Portogallo 2
PY - Paraguay 2
SN - Senegal 2
TH - Thailandia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
GF - Guiana Francese 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
MA - Marocco 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
PW - Palau 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SV - El Salvador 1
TW - Taiwan 1
TZ - Tanzania 1
VC - Saint Vincent e Grenadine 1
Totale 14.030
Città #
Woodbridge 2.662
Wilmington 2.530
Houston 2.527
Singapore 436
Fairfield 335
Chandler 257
Ashburn 246
Ann Arbor 243
San Jose 165
Seattle 141
Rome 132
Cambridge 131
Hong Kong 122
Dublin 116
Beijing 101
Council Bluffs 101
Dearborn 92
Dallas 86
Medford 83
New York 80
Jacksonville 77
Santa Clara 63
Ho Chi Minh City 54
Los Angeles 52
Lawrence 39
The Dalles 34
Hanoi 32
Buffalo 31
Lauterbourg 31
Tokyo 31
Kraków 30
Moscow 24
Menlo Park 21
Milan 21
San Diego 21
São Paulo 19
Zhengzhou 18
London 16
Colorado Springs 15
Nuremberg 15
Chennai 14
Chicago 13
Hackensack 13
Helsinki 13
Jakarta 13
Brussels 12
Atlanta 10
Munich 10
Seoul 10
Amsterdam 9
Brooklyn 9
Engelhard 9
Montreal 9
Perugia 9
Toronto 9
Verona 9
Warsaw 9
Boardman 8
Kunming 8
La Veta 8
Frankfurt am Main 7
Norwalk 7
Center 6
Charlotte 6
Columbus 6
Falls Church 6
Florence 6
Haiphong 6
Mülheim 6
Orem 6
Paris 6
Phoenix 6
Redondo Beach 6
Redwood City 6
Shanghai 6
Vienna 6
Bari 5
Brasília 5
Cairo 5
Curitiba 5
Da Nang 5
Stockholm 5
Tashkent 5
Belo Horizonte 4
Blumenau 4
Brno 4
Creede 4
Denver 4
Istanbul 4
Johannesburg 4
Lappeenranta 4
Madrid 4
Manchester 4
Mexico City 4
Mountain View 4
Nanjing 4
Naples 4
North Bergen 4
Pune 4
Querétaro 4
Totale 11.635
Nome #
Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia 523
A case of SRSF2 mutation in chronic lymphocytic leukemia 518
An allele-specific RT-PCR assay to detect type A mutation of the nucleophosmin-1 gene in acute myeloid leukemia 506
Identification of a potential topoisomerase II “hotspot” DNA region in the DEK gene in two t(6;9)-positive therapy-related myeloid neoplasms 476
Development of a High-Resolution Melting Curve Analysis Screening Test for SRSF2 Splicing Factor Gene Mutations in Myelodysplastic Syndromes 469
PML nuclear body disruption impairs DNA double-strand break sensing and repair in APL 458
PML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity 458
Cytotoxic effects of high concentrations of sodium ascorbate on human myeloid cell lines 457
MEK1 inhibition sensitizes primary acute myelogenous leukemia to arsenic trioxide-induced apoptosis 451
Rapid detection of IDH2 (R140Q and R172K) mutations in acute myeloid leukemia 451
Rapid detection of nucleophosmin (NPM1) mutations in acute myeloid leukemia by denaturing HPLC 439
Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress 416
Alterations of the FLT3 gene in acute promyelocytic leukemia: Association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol 415
Role of γ-glutamyl cysteine synthetase (γ-GCS) gene expression as marker of drug sensitivity in acute myeloid leukemias 408
Diagnostic value of detecting fusion proteins derived from chromosome translocations in acute leukaemia 408
Identification of a potential hotspot DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocation 407
Treatment of acute promyelocytic leukemia with gemtuzumab ozogamicin 407
Gentuzumab ozogamicin ("mylotarg") as a single agent for molecularly relapsed acute promyelocytic leukemia 398
Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expression. 395
The forkhead box C1 (FOXC1) transcription factor is downregulated in acute promyelocytic leukemia 393
Role of GSTP1-1 in mediating the effect of As2O3 in the Acute Promyelocytic Leukemia cell line NB4 388
Nucleophosmin/B26 regulates PTEN through interaction with HAUSP in acute myeloid leukemia 381
Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy. 380
Identification of a potential "Hotspot" DNA region in the RUNXI gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocation 378
PML/RARA inhibits expression of HSP90 and its target AKT 367
Acute promyelocytic Leukemia: Update on the mechanisms of leukemogenesis, resistance and on innovative treatment strategies 272
PML/RARa interferes with NRF2 transcriptional activity increasing the sensitivity to ascorbate of acute promyelocytic leukemia cells 244
Double remission of simultaneously occurring secondary AML and CLL by venetoclax monotherapy 199
Retinoic acid synergizes with the unfolded protein response and oxidative stress to induce cell death in FLT3-ITD+ AML 188
Absence of FGFR3-TACC3 rearrangement in hematological malignancies with numerical chromosomal alteration 181
Leukemia-Associated CD34/CD123/CD25/CD99-positive Immunophenotype Identifies FLT3-mutated Clones in Acute Myeloid Leukemia. 168
Clonal genetic evolution at relapse of favorable-risk acute myeloid leukemia with NPM1 mutation is associated with phenotypic changes and worse outcomes 134
MCL1 regulates AML cells metabolism via direct interaction with HK2. Metabolic signature at onset predicts overall survival in AMLs' patients 133
CD99 as a novel therapeutic target on leukemic progenitor cells in FLT3-ITDmut AML 131
Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment 124
NPM1 mutated, BCR-ABL1 positive myeloid neoplasms: review of the literature 115
Decitabine treatment of multiple extramedullary acute myeloid leukemia involvements after essential thrombocytemia transformation. 114
The Anti-Leukemia Effect of Ascorbic Acid: From the Pro-Oxidant Potential to the Epigenetic Role in Acute Myeloid Leukemia 108
PLZF-RARΑ ENHANCES METABOLIC PLASTICITY AND ROS SCAVENGING IN AML CELLS 101
Decitabine as salvage therapy for primary induction failure of acute myeloid leukemia. 101
Transcriptional and metabolic dissection of ATRA-induced granulocytic differentiation in NB4 acute promyelocytic leukemia cells 98
Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies 90
Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia 89
Characterization of a novel IDH2‐R159H mutation in acute myeloid leukaemia: Effects on cell metabolism and differentiation 88
Treatment free remission in chronic myeloid leukemia: Lights and shadows 86
Genetic lesions disrupting calreticulin 3'-untranslated region in JAK2 mutation-negative polycythemia vera 84
YY1 Knockdown Relieves the Differentiation Block and Restores Apoptosis in AML Cells 79
The Combination of Gefitinib With ATRA and ATO Induces Myeloid Differentiation in Acute Promyelocytic Leukemia Resistant Cells 77
Editorial: Metabolic Rewiring in Leukemias 75
PML::RARα+ myeloid cells display metabolic alterations that can be targeted to treat resistant/relapse acute promyelocytic leukemias 74
Effects of Triheptanoin on Mitochondrial Respiration and Glycolysis in Cultured Fibroblasts from Neutral Lipid Storage Disease Type M (NLSD-M) Patients 67
Venetoclax and new BCL-2 inhibitors in acute myeloid leukemia 63
Molecular Targets of Oxidative Stress: Focus on Nuclear Factor Erythroid 2–Related Factor 2 Function in Leukemia and Other Cancers 51
Correction: Niscola et al. Acute Myeloid Leukemia in Older Patients: From New Biological Insights to Targeted Therapies. Curr. Oncol. 2024, 31, 6632–6658 46
PKP1 promotes lung cancer by modulating energy metabolism through stabilization of PFKP 42
Metabolic Signature of FLT3-Mutated AML: Clinical and Therapeutic Implications 37
New horizons for hope of cure in acute myeloid leukemia through immunotherapy: a narrative review 14
Totale 14.220
Categoria #
all - tutte 37.369
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.369


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022419 23 48 15 18 15 21 26 16 24 45 43 125
2022/2023658 61 48 27 100 61 132 63 34 65 5 31 31
2023/2024308 60 13 31 8 20 69 16 2 13 9 12 55
2024/20251.014 54 241 111 84 11 70 119 46 88 52 86 52
2025/20262.428 180 72 282 176 194 83 351 245 275 283 135 152
2026/202732 32 0 0 0 0 0 0 0 0 0 0 0
Totale 14.220